• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. MCRYL VIO 36IN 1 S/A CTX; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. MCRYL VIO 36IN 1 S/A CTX; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Model Number Y399H
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code Wound Dehiscence (1154)
Date of Event 02/26/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, weight, bmi at the time of index procedure what were current symptoms following the index surgical procedure? onset date? other relevant patient history/concomitant medications? what tissue type and location of the suture placement? what tissue dehisced? what was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? how was suture initially placed (interrupted or continuous)? was there any precipitating stress factor for the sutures untying, breakage or pulling out of the tissue? did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement and during re-operation? what is physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient current status? analysis summary: visual inspection of eleven unopened samples and no defects were found on the package.The samples were opened, and the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strand and no defects, damage or suture breakage were noted.A functional test was performed using an instron and the tensile strength force was above the minimum requirement.The device performed without any defect noted.A manufacturing record evaluation was performed for the finished device batch, and no non-conformances were identified.(b)(4).
 
Event or Problem Description
It was reported that a patient underwent a c-section procedure on (b)(6) 2021 and suture was used.One day post-op, the incision had dehisced, and the patient's bowels were coming out.The patient was rushed to operating room where the surgeon believed that the suture failed at the midline of the incision.The patient doing fine and was discharged (b)(6) 2021.Additional information requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MCRYL VIO 36IN 1 S/A CTX
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key11530082
Report Number2210968-2021-02564
Device Sequence Number5425081
Product Code GAN
UDI-Device Identifier10705031059108
UDI-Public10705031059108
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K960653
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2025
Device Model NumberY399H
Device Catalogue NumberY399H
Device Lot NumberQJMJLB
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2021
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/03/2021
Initial Report FDA Received Date03/19/2021
Patient Sequence Number1
-
-